TipRanks
Impedimed Limited (AU:IPD)
ASX:IPD
Australian Market
IPD
Impedimed Limited
RESEARCH TOOLSreports
Want to see AU:IPD full AI Analyst Report?

Impedimed Limited (IPD) Stock News & Sentiment

29 Followers
Impedimed Earnings Call: Growth Potential Amid Execution Risk
Premium
Company Announcements
Impedimed Earnings Call: Growth Potential Amid Execution Risk
1d ago
ImpediMed Releases Investor Presentation on Q1 FY27 Results
Premium
Company Announcements
ImpediMed Releases Investor Presentation on Q1 FY27 Results
2d ago
Impedimed Director Boosts Equity Stake Through Fee-For-Shares Arrangement
Premium
Company Announcements
Impedimed Director Boosts Equity Stake Through Fee-For-Shares Arrangement
4d ago
ImpediMed Director Boosts Indirect Shareholding Through Fee-Paid Share Issue
Premium
Company Announcements
ImpediMed Director Boosts Indirect Shareholding Through Fee-Paid Share Issue
4d ago
ImpediMed director boosts stake through fee-for-shares arrangement
Premium
Company Announcements
ImpediMed director boosts stake through fee-for-shares arrangement
4d ago
ImpediMed Director Increases Stake Through Equity-Based Fee Arrangement
Premium
Company Announcements
ImpediMed Director Increases Stake Through Equity-Based Fee Arrangement
4d ago
Impedimed Issues New Shares to Directors Under Equity Fee Plan
Premium
Company Announcements
Impedimed Issues New Shares to Directors Under Equity Fee Plan
4d ago
More AU:IPD News >

IPD News on the Web

ImpediMed sets date for Q1 FY27 cash flow release and investor webinar
TipRanks News
Neutral
ImpediMed Discloses Director Share Transfer Following Financial Settlement
TipRanks News
Neutral
ImpediMed Director Erik Anderson Significantly Increases Shareholding
TipRanks News
Bullish
ImpediMed Sets November Date for 2026 AGM and Board Nomination Deadline
TipRanks News
Neutral
ImpediMed Limited (ASX:IPD) Just Reported, And Analysts Assigned A AU$0.021 Price Target
Simply Wall St
Neutral
ImpediMed lodges 2026 Corporate Governance Statement and Appendix 4G
TipRanks News
Neutral
ImpediMed gains FDA clearance for SOZO sarcopenia risk assessment
Proactive Investors
Bullish
ImpediMed Wins FDA Nod for SOZO Sarcopenia Risk Assessment
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
AU:IPD
Sector Average
Media Buzz
This Week8 articles
Weekly Average1 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:IPD’s Media Buzz Sentiment?
8 articles about AU:IPD were published this week. In an average week, 1 articles are published.
    What is AU:IPD’s weekly average amount of articles?
    In an average week, 1 articles about AU:IPD are published.
      What is AU:IPD’s News Sentiment?
      100% of articles about AU:IPD were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week